Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach

Standard

Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach. / Seiffert, Moritz; Conradi, Lenard; Baldus, Stephan; Schirmer, Johannes; Blankenberg, Stefan; Reichenspurner, Hermann; Diemert, Patrick; Treede, Hendrik.

In: EUR J CARDIO-THORAC, Vol. 44, No. 3, 09.2013, p. 478-484.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{590cf72c8e9d48a59a738bd8e258a358,
title = "Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach",
abstract = "OBJECTIVES: Transcatheter aortic valve implantation (TAVI) has emerged rapidly. Despite unanimous recommendations and potentially fatal intraoperative complications, the heart-team approach is not comprehensively adopted by all centres. We sought to characterize severe intraprocedural complications during TAVI requiring immediate surgical or interventional bailout manoeuvres and evaluate outcomes.METHODS: TAVI was performed in 458 consecutive patients using a balloon-expandable or self-expanding valve through transfemoral and transapical approaches. Severe intraprocedural complications requiring intraoperative bailout manoeuvres were analysed according to the Valve Academic Research Consortium (VARC) criteria.RESULTS: Thirty-five of 458 patients (7.6%) experienced 40 major intraprocedural complications during TAVI, 13 (2.8%) requiring emergent conversion to surgery. Complications included valve embolization/migration (17%), severe aortic regurgitation (12%) and root rupture (5%), requiring immediate implantation of a second valve or conversion to surgical valve replacement. Sternotomy and surgical haemostasis were performed in 5 patients (13%) with left ventricular wire perforation and subsequent cardiac tamponade. Coronary obstruction (15%) required emergent percutaneous coronary intervention in 6 patients. At 30 days, all-cause mortality was 31.4% in patients with intraprocedural complications and 38.5% in patients requiring surgical conversion. However, mid-term survival after 30 days and exercise tolerance in surviving patients were comparable with patients undergoing uncomplicated TAVI.CONCLUSIONS: An interdisciplinary approach to TAVI facilitated bailout procedures accomplishing acceptable outcomes, despite severe intraprocedural complications. These bailout manoeuvres in potentially fatal complications were only accomplished through an interdisciplinary heart-team effort, creating a surgical and interventional safety net, which should be established in all centres performing TAVI procedures.",
keywords = "Aged, Aged, 80 and over, Female, Heart Valve Prosthesis Implantation/adverse effects, Humans, Intraoperative Complications/etiology, Kaplan-Meier Estimate, Male, Postoperative Complications/etiology, Treatment Outcome",
author = "Moritz Seiffert and Lenard Conradi and Stephan Baldus and Johannes Schirmer and Stefan Blankenberg and Hermann Reichenspurner and Patrick Diemert and Hendrik Treede",
year = "2013",
month = sep,
doi = "10.1093/ejcts/ezt032",
language = "English",
volume = "44",
pages = "478--484",
journal = "EUR J CARDIO-THORAC",
issn = "1010-7940",
publisher = "Elsevier",
number = "3",

}

RIS

TY - JOUR

T1 - Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach

AU - Seiffert, Moritz

AU - Conradi, Lenard

AU - Baldus, Stephan

AU - Schirmer, Johannes

AU - Blankenberg, Stefan

AU - Reichenspurner, Hermann

AU - Diemert, Patrick

AU - Treede, Hendrik

PY - 2013/9

Y1 - 2013/9

N2 - OBJECTIVES: Transcatheter aortic valve implantation (TAVI) has emerged rapidly. Despite unanimous recommendations and potentially fatal intraoperative complications, the heart-team approach is not comprehensively adopted by all centres. We sought to characterize severe intraprocedural complications during TAVI requiring immediate surgical or interventional bailout manoeuvres and evaluate outcomes.METHODS: TAVI was performed in 458 consecutive patients using a balloon-expandable or self-expanding valve through transfemoral and transapical approaches. Severe intraprocedural complications requiring intraoperative bailout manoeuvres were analysed according to the Valve Academic Research Consortium (VARC) criteria.RESULTS: Thirty-five of 458 patients (7.6%) experienced 40 major intraprocedural complications during TAVI, 13 (2.8%) requiring emergent conversion to surgery. Complications included valve embolization/migration (17%), severe aortic regurgitation (12%) and root rupture (5%), requiring immediate implantation of a second valve or conversion to surgical valve replacement. Sternotomy and surgical haemostasis were performed in 5 patients (13%) with left ventricular wire perforation and subsequent cardiac tamponade. Coronary obstruction (15%) required emergent percutaneous coronary intervention in 6 patients. At 30 days, all-cause mortality was 31.4% in patients with intraprocedural complications and 38.5% in patients requiring surgical conversion. However, mid-term survival after 30 days and exercise tolerance in surviving patients were comparable with patients undergoing uncomplicated TAVI.CONCLUSIONS: An interdisciplinary approach to TAVI facilitated bailout procedures accomplishing acceptable outcomes, despite severe intraprocedural complications. These bailout manoeuvres in potentially fatal complications were only accomplished through an interdisciplinary heart-team effort, creating a surgical and interventional safety net, which should be established in all centres performing TAVI procedures.

AB - OBJECTIVES: Transcatheter aortic valve implantation (TAVI) has emerged rapidly. Despite unanimous recommendations and potentially fatal intraoperative complications, the heart-team approach is not comprehensively adopted by all centres. We sought to characterize severe intraprocedural complications during TAVI requiring immediate surgical or interventional bailout manoeuvres and evaluate outcomes.METHODS: TAVI was performed in 458 consecutive patients using a balloon-expandable or self-expanding valve through transfemoral and transapical approaches. Severe intraprocedural complications requiring intraoperative bailout manoeuvres were analysed according to the Valve Academic Research Consortium (VARC) criteria.RESULTS: Thirty-five of 458 patients (7.6%) experienced 40 major intraprocedural complications during TAVI, 13 (2.8%) requiring emergent conversion to surgery. Complications included valve embolization/migration (17%), severe aortic regurgitation (12%) and root rupture (5%), requiring immediate implantation of a second valve or conversion to surgical valve replacement. Sternotomy and surgical haemostasis were performed in 5 patients (13%) with left ventricular wire perforation and subsequent cardiac tamponade. Coronary obstruction (15%) required emergent percutaneous coronary intervention in 6 patients. At 30 days, all-cause mortality was 31.4% in patients with intraprocedural complications and 38.5% in patients requiring surgical conversion. However, mid-term survival after 30 days and exercise tolerance in surviving patients were comparable with patients undergoing uncomplicated TAVI.CONCLUSIONS: An interdisciplinary approach to TAVI facilitated bailout procedures accomplishing acceptable outcomes, despite severe intraprocedural complications. These bailout manoeuvres in potentially fatal complications were only accomplished through an interdisciplinary heart-team effort, creating a surgical and interventional safety net, which should be established in all centres performing TAVI procedures.

KW - Aged

KW - Aged, 80 and over

KW - Female

KW - Heart Valve Prosthesis Implantation/adverse effects

KW - Humans

KW - Intraoperative Complications/etiology

KW - Kaplan-Meier Estimate

KW - Male

KW - Postoperative Complications/etiology

KW - Treatment Outcome

U2 - 10.1093/ejcts/ezt032

DO - 10.1093/ejcts/ezt032

M3 - SCORING: Journal article

C2 - 23389474

VL - 44

SP - 478

EP - 484

JO - EUR J CARDIO-THORAC

JF - EUR J CARDIO-THORAC

SN - 1010-7940

IS - 3

ER -